The NIH disbursed more than $4 billion in funding to large consortiums and clinical trials to develop diagnostics, therapeutics, and vaccines. Approximately 8% of funding was used for R01 grants. Clinical trial sites were generally located in areas of high COVID-19 burden.
All Keywords
【저자키워드】 COVID-19, SARS CoV-2, clinical trials, grants, NIH funding,
【저자키워드】 COVID-19, SARS CoV-2, clinical trials, grants, NIH funding,